MIND Prize
The MIND Prize funds bold, interdisciplinary research to advance breakthroughs in neurodegenerative diseases, supporting early-to-mid-career scientists tackling high-risk, transformative projects.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years, including up to 10% indirect costs)
Summary: Supports early-to-mid-career researchers pursuing innovative, high-risk research on neurodegenerative diseases through interdisciplinary collaboration.
Key Information: Applicants may only apply to one Pershing Square Foundation prize program per year and no more than three times total.
Description
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize, offered by Pershing Square Philanthropies, is designed to accelerate breakthroughs in neurodegenerative disease (NDD) research, including Alzheimer's Disease and Dementia. The program funds early-to-mid-career investigators who propose bold, high-risk, and interdisciplinary projects that challenge conventional paradigms and have the potential for transformative impact. Projects can span a wide range of research areas, including neurobiology, brain imaging, machine learning, drug delivery, and synthetic biology. Recipients join a unique network of researchers, benefit from facilitated collaborations, and gain access to networking events with industry and investors.
